Cardiol Therapeutics clinical trials we track

Check company identity source

Phase 3 1 trial

TrialDrugs studiedStatusPrimary completion
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)NCT06708299CardiolRxRecruiting2026-09-21Estimated

Phase 2 / 3 1 trial

Phase 2 2 trials

TrialDrugs studiedStatusPrimary completion
Impact of CardiolRx on Myocardial Recovery in Patients With Acute MyocarditisNCT05180240CardiolRxCompleted2025-01-31Actual
Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot)NCT05494788CardiolRxCompleted2024-06-15Actual

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)

NCT06708299 · Cardiol Therapeutics Inc.

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Recurrence of pericarditis. After: Measure: time to pericarditis recurrence.

Check registry source

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: extracellular volume (ECV) Measure: Global longitudinal Strain (GLS). After: Measure: Extracellular Volume (ECV) Measure: Global Longitudinal Strain (GLS).

Check registry source

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: All-cause Mortality. After: Measure: Composite of All-cause Mortality, Requirement for ICU Admission and/or Ventillatory Support and Cardiovascular Complications.

Check registry source